MSD main partner of Trendtage Gesundheit Luzern 2018

Lucerne, 28 February 2018 - This year's Trendtage Gesundheit (Health Trend Days) will take place at the KKL Lucerne on 28 February and 1 March 2018. Around 700 opinion leaders and decision-makers from the fields of medicine, science, business and politics will be discussing trends and perspectives in the healthcare sector at this established national event. “BE SMART - the search for smart decisions for prudent medicine" is the focus of the Trendtage Gesundheit 2018. For the sixth time, MSD is the main partner of the event.

As a leading biopharmaceutical company, MSD employs 700 people at four locations in the canton of Lucerne. It is thus one of the largest employers in the region and is firmly anchored there. Dr. Angelika März, Director of Policy & Communications at MSD in Switzerland: "Long-term local commitments are very important to us. The Trendtage Gesundheit are a platform that we have been committed to supporting for years. As a main partner, we are a member of the Advisory Board and participate in the definition of the agenda and congress program. We are also actively involved in the debate."

This year Alexander Rödiger, Policy Lead Oncology Europe, Middle East, Africa and Canada at MSD, will speak on "Immuno-oncology: Potential and Development" on March 1 at 2 pm. “In the health care sector, "BE SMART" means networking and cooperation of all parties involved: patients, health care professionals, payers, authorities and companies. A single actor cannot face up to the questions of prioritizing and financing health care in our ageing society".


Dr. Angelika März
Director Policy & Communications at MSD

Alexander Rödiger
Policy Lead Oncology – Europe, Middle East, Africa and Canada at MSD

MSD is engaged in other local projects and initiatives to improve the health of patients in Switzerland. These include the Swiss Congress for Health Economics and Health Sciences, which was initiated in 2003, and the Alliance for Health Literacy, which MSD has been a member of since its foundation in 2010.

More information: msd.ch/en/partner

About MSD

MSD is a leading global biopharmaceutical company which has been engaged in life science research for more than a century, developing drugs and vaccines for the most challenging diseases worldwide. MSD is a registered trademark of Merck & Co., Inc., Kenilworth, New Jersey, USA. With our prescription drugs, vaccines, biological therapies, and veterinary products, we offer innovative health solutions in over 140 countries. With wide-ranging programs and partnerships, we are also committed to achieving improved access to healthcare. Today MSD is still at the forefront of research for the prevention and treatment of diseases which threaten people and society around the world, including cancer, cardiovascular diseases, new animal diseases, Alzheimer’s, and infectious diseases, including HIV and Ebola. For more information visit www.msd.com and follow us on Twitter.

MSD Human Medicine Switzerland

Switzerland is a key location for the company, which has 700 employees working there in national and international functions. The Human Medicine division in Switzerland is responsible for the distribution of prescription drugs and biopharmaceuticals in the areas of oncology, diabetes, cardiovascular diseases, infectious diseases (including fungal infections, antibiotic resistance, HIV/Aids, and hepatitis C), immunology, women’s health as well as vaccines for children, young people, and adults.

MSD is active in clinical research in Switzerland, where the company provides medicines for clinical trials worldwide. Additionally, MSD is committed to raising health literacy and promoting the healthcare economy on a local level. The company is also active in Lucerne, where the MSD headquarters are located. In 2018 the company received certification as a “Top Employer” in Switzerland for the sixth year in succession, as well as the “Top Employer Europe” award for the third time.

More information is available at: www.msd.ch

Press contact:
Liliane Elspass, Lead Communications
MSD Merck Sharp & Dohme AG
Tel. +41 58 618 34 24 / Mobile 079 235 58 90
media.switzerland@merck.com

© 2018 MSD Merck Sharp & Dohme AG, Werftestrasse 4, 6005 Lucerne. All rights reserved.

CORP-1241900-0018, February 2018